Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Esonium - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Esonium

Approved

STANDARD

Esonium

Lyka Labs Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 0fcac9c28282a64c
Company: Lyka Labs Limited
Type: Standard

Approval Details

Approval Id: 0fcac9c28282a64c
Drug Approval Philippines Name: Esonium
Product Name: Esonium
Registration Number: DRP-2361
Brand Name: Esonium
Generic Name: Esomeprazole (As Sodium)
Dosage Form: Powder For Injection
Dosage Strength: 40mg
Manufacturer: Lyka Labs Limited
Importer: Cris Pharma House
Distributor: Cris Pharma House
Company Detail Path: /organization/lyka-labs-limited
Issuance Date: 27 May 2022
Expiry Date: 05 August 2027
Pharmacologic Category: PROTON PUMP INHIBITOR
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

0fcac9c28282a64c

Type

Standard

Back to Philippines FDA Approvals